Open access
Sep 2026
Naphthalimide-based andrographolide nanoplatform suppresses ccRCC via targeting the HIF-2α/VEGF signaling axis
A naphthalimide-based multifunctional nanoplatform was developed as a drug delivery system for andrographolide (AG) to improve its therapeutic specificity and provide a potential nanocarrier strategy for targeting the HIF-2α/VEGF signaling axis in ccRCC.
Jun Du, Chao Zhang, Li Zhang et al.
· Arabian Journal of Chemistry · 0 citations